Shares of Nevro Corp. (NYSE:NVRO – Get Free Report) have earned a consensus rating of “Reduce” from the thirteen brokerages that are presently covering the firm, Marketbeat.com reports. Two investment ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...